Evidence map›Paper›PMID 24922324›Full record

ArticleRNA biology2014

Annotation of long non-coding RNAs expressed in collaborative cross founder mice in response to respiratory virus infection reveals a new class of interferon-stimulated transcripts.

Laurence Josset, Nicolas Tchitchek, Lisa E Gralinski, Martin T Ferris, Amie J Eisfeld, Richard R Green, Matthew J Thomas, Jennifer Tisoncik-Go, Gary P Schroth, Yoshihiro Kawaoka and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in RNA biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 112 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Human long noncoding RNAJournal of virology · 2025
    Article
  6. Computational Resources for lncRNA Functions and Targetome.Methods in molecular biology (Clifton, N.J.) · 2025
    Review
  7. Review
  8. Article
  9. Human long noncoding RNA,bioRxiv : the preprint server for biology · 2024
    Article
  10. Article
  11. Plumbing mysterious RNAs in "dark genome" for the conquest of human diseases.Molecular therapy : the journal of the American Society of Gene Therapy · 2023
    Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 2 countries.

Laurence JossetDepartment of Microbiology; School of Medicine; University of Washington; Seattle, WA USA; Pacific Northwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research; Portland, OR USA.
Nicolas TchitchekDepartment of Microbiology; School of Medicine; University of Washington; Seattle, WA USA; Pacific Northwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research; Portland, OR USA.
Lisa E GralinskiPacific Northwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research; Portland, OR USA; Department of Epidemiology; University of North Carolina-Chapel Hill; Chapel Hill, NC USA.
Martin T FerrisPacific Northwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research; Portland, OR USA; Department of Genetics; University of North Carolina-Chapel Hill; Chapel Hill, NC USA.
Amie J EisfeldDepartment of Pathobiological Sciences; Influenza Research Institute; University of Wisconsin-Madison; Madison, WI USA.
Richard R GreenDepartment of Microbiology; School of Medicine; University of Washington; Seattle, WA USA; Pacific Northwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research; Portland, OR USA.
Matthew J ThomasDepartment of Microbiology; School of Medicine; University of Washington; Seattle, WA USA; Pacific Northwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research; Portland, OR USA.
Jennifer Tisoncik-GoDepartment of Microbiology; School of Medicine; University of Washington; Seattle, WA USA; Pacific Northwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research; Portland, OR USA.
Gary P SchrothIllumina, Inc.; San Diego, CA USA.
Yoshihiro KawaokaDepartment of Pathobiological Sciences; Influenza Research Institute; University of Wisconsin-Madison; Madison, WI USA.
Fernando Pardo Manuel de VillenaDepartment of Genetics; University of North Carolina-Chapel Hill; Chapel Hill, NC USA.
Ralph S BaricPacific Northwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research; Portland, OR USA; Department of Epidemiology; University of North Carolina-Chapel Hill; Chapel Hill, NC USA.
Mark T HeisePacific Northwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research; Portland, OR USA; Department of Genetics; University of North Carolina-Chapel Hill; Chapel Hill, NC USA.
Xinxia PengDepartment of Microbiology; School of Medicine; University of Washington; Seattle, WA USA; Pacific Northwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research; Portland, OR USA.
Michael G KatzeDepartment of Microbiology; School of Medicine; University of Washington; Seattle, WA USA; Pacific Northwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research; Portland, OR USA.
Oregon Medical Research Center · USSeattle University · USCommunities In Schools of Orange County · USIllumina (United States) · USIndiana University School of MedicineResearch Institute of Influenza · RUSeattle Pacific University · USUniversity of North Carolina at Chapel Hill · USUniversity of Wisconsin–Madison · US

Funding

The Burden of Chikungunya and Dengue Infection in KenyaU54AI081680 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI RYMAN, KATHERINE D · 2009 to 2013
$40.4M
Unlocking Zika Virus Immune Control and Pathogenesis with the Collaborative CrossU19AI100625 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HEISE, MARK T · 2012 to 2021
$36.6M
NIAID NIH HHS HHSN272200800060CNIAID NIH HHS U19 AI100625NIAID NIH HHS U19 AI100625-02NIAID NIH HHS U54 AI081680NIAID NIH HHS U54AI081680
6 · The paper itself

Abstract

The outcome of respiratory virus infection is determined by a complex interplay of viral and host factors. Some potentially important host factors for the antiviral response, whose functions remain largely unexplored, are long non-coding RNAs (lncRNAs). Here we systematically inferred the regulatory functions of host lncRNAs in response to influenza A virus and severe acute respiratory syndrome coronavirus (SARS-CoV) based on their similarity in expression with genes of known function. We performed total RNA-Seq on viral-infected lungs from eight mouse strains, yielding a large data set of transcriptional responses. Overall 5,329 lncRNAs were differentially expressed after infection. Most of the lncRNAs were co-expressed with coding genes in modules enriched in genes associated with lung homeostasis pathways or immune response processes. Each lncRNA was further individually annotated using a rank-based method, enabling us to associate 5,295 lncRNAs to at least one gene set and to predict their potential cis effects. We validated the lncRNAs predicted to be interferon-stimulated by profiling mouse responses after interferon-α treatment. Altogether, these results provide a broad categorization of potential lncRNA functions and identify subsets of lncRNAs with likely key roles in respiratory virus pathogenesis. These data are fully accessible through the MOuse NOn-Code Lung interactive database (MONOCLdb).

Indexed as

AnimalsAntiviral AgentsCell LineFemaleGene Expression ProfilingGene Expression RegulationInfluenza A virusInterferon-alphaLungMiceMice, Inbred C57BLMolecular Sequence AnnotationRNA, Long NoncodingRNA Virus InfectionsSequence Analysis, RNASevere acute respiratory syndrome-related coronavirusAntiviral AgentsInterferon-alphaRNA, Long Noncodingcollaborative crossinfluenza virusinterferonlong non-coding rnarna-seqsars-cov

Identifiers

PMID24922324
PMCPMC4179962
OpenAlexW1980508395

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.